CIK 0001314052 · Large accelerated filer<br>Smaller reporting company
ANAVEX LIFE SCIENCES CORP.
Sign in to watch- Ticker
- AVXL
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Sep 30
- Entity type
- operating
- EIN
- 980608404
- Phone
- 844-689-3939
- Business address
- 630 5TH AVENUE, 20TH FLOOR, NEW YORK, NY, 10111
- Former names
- Thrifty Printing Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2008-06-03 | Lalach Harvey President, CFO | Grant or award · Stock Options | +150,000 | $5.00 | $750K | 150,000 |
| 2008-05-20 | Durrant Cameron Director | Grant or award · stock options | +400,000 | 550,000 | ||
| 2007-10-26 | Skarpelos Athanasios 10% owner | Sale | −950,000 | $1.70 | $1.6M | 7,567,500 |
| 2007-09-17 | Skarpelos Athanasios 10% owner | Purchase | +92,500 | $3.60 | $333K | 8,517,500 |
| 2007-07-30 | Skarpelos Athanasios 10% owner | Sale | −950,000 | $1.70 | $1.6M | 8,425,000 |
| 2007-02-08 | Kontzalis Panos CEO | Purchase · Stock Option | +200,000 | 200,000 | ||
| 2007-02-08 | Kalkanis George VP Strategic Planning | Purchase · Stock Option | +150,000 | 150,000 | ||
| 2007-02-08 | Vernadaki Angela VP Business Development | Purchase · Stock Option | +150,000 | 150,000 | ||
| 2006-06-12 | Skarpelos Athanasios 10% owner | Other acquisition | +7,812,500 | 9,375,000 | ||
| 2006-06-12 | Lalach Harvey President & CEO | Other acquisition | +500,000 | 600,000 | ||
| 2006-04-25 | Wu Yang President & CEO | Sale | −812,500 | $0.15 | $122K | 0 |
| 2006-04-25 | Wu Pei Ru COO | Sale | −850,000 | $0.15 | $128K | 0 |
Page 12 of 12 · 232 trades